VHL is also mutated or methylated in up to 90% of ccRCC (Cancer Genome Atlas Research Network, 2013; Gnarra et al., 1994; Nickerson et al., 2008), the most common kidney cancer subtype comprising about 75% of all RCC cases (Linehan & Schmidt, 2019). Here, VHL is linked to nonpapillary renal cell carcinoma.